{"id":"W3167076087","doi":"10.1200/jco.2021.39.15_suppl.1061","title":"Results from CONTESSA 2: A multinational, multicenter, phase 2 study of tesetaxel (T) plus a reduced dose of capecitabine (C) in patients (pts) with hormone receptor + (HR+), HER2- metastatic breast cancer (MBC) not previously treated with a taxane.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Taxane; Capecitabine; Metastatic breast cancer; Clinical endpoint; Internal medicine; Breast cancer; Phases of clinical research; Cancer; Oncology; Gastroenterology; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003087313,0.002443502,0.001892927,0.0006250848,0.0006381165,0.00133716,0.001287575,0.001870916,0.005220012],"category_scores_gemma":[0.002314856,0.0007107771,0.00227077,0.0005981817,0.001228541,0.001306262,0.0005224389,0.004326325,0.001219013],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001542656,"about_ca_system_score_gemma":0.002313683,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002639442,"about_ca_topic_score_gemma":0.007695716,"domain_scores_codex":[0.9992321,0.0004132567,0.00003081873,0.0001332646,0.00008655601,0.0001039759],"domain_scores_gemma":[0.9984826,0.000384375,0.0002775706,0.0001162865,0.00008547415,0.0006536351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7605565,0.07334906,0.0108193,0.00102301,0.002877153,0.0003313829,0.0005863641,0.003319199,0.03101853,0.0004730933,0.01339758,0.1022489],"study_design_scores_gemma":[0.6616041,0.3105251,0.01790219,0.00007629706,0.0009815866,0.0003671106,0.00008442908,0.001074782,0.002123521,0.0002595985,0.004944743,0.00005651443],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9812565,0.004291358,0.0006179256,0.001826139,0.0003103325,0.002908648,0.004007757,0.0001697471,0.00461162],"genre_scores_gemma":[0.962085,0.004281009,0.003345331,0.002851715,0.0005482864,0.00427454,0.01376385,0.0001532337,0.008696961],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005220012,"threshold_uncertainty_score":0.01746273,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09543072615978272,"score_gpt":0.4480371251360116,"score_spread":0.3526063989762289,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}